Ignite Creation Date:
2025-12-24 @ 12:18 PM
Ignite Modification Date:
2026-01-26 @ 12:18 AM
Study NCT ID:
NCT00976261
Status:
COMPLETED
Last Update Posted:
2017-06-08
First Post:
2009-09-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2010-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-11
First Submit QC Date:
None
Study First Post Date:
2009-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-07
Last Update Post Date:
2017-06-08
Last Update Post Date Type:
ACTUAL